Clinical Trial Update: Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck [Phase 2]

View source ↗

Summary

This phase 2 clinical trial evaluated the response rate to a combination of docetaxel and cisplatin in unresectable locally advanced squamous cell carcinoma of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of Head and Neck

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 2 | Status: COMPLETED